Cerespir
New York, US · Founded 2013 · Delaware corporation · 1 known investors
Pharmaceutical company developing novel approach to Alzheimer's disease
Founders & leadership
Cerespir was founded in 2013 by Daniel G. Chain.
DG
Daniel G. ChainFounder
AN
Adrian N. HobdenExecutive
Board
SJ
Samuel JesselsonBoard director
MJ
Michael JesselsonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2016
▶$500KraisedSep 2016 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adrian N. HobdenExecutive Officer, Director
- Daniel G. ChainExecutive Officer, Director
- Samuel JesselsonDirector
- Michael JesselsonDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Proceeds to insiders
- $135K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cerespir do?
- Pharmaceutical company developing novel approach to Alzheimer's disease
- Who founded Cerespir?
- Cerespir was founded by Daniel G. Chain in 2013.
- Who are Cerespir's investors?
- Cerespir's investors include Vedanta Capital.
- How much funding has Cerespir raised?
- Cerespir has disclosed $500K raised across 1 round.
- Where is Cerespir headquartered?
- Cerespir is headquartered in New York, US.